FDA Approves Topical Tapinarof for Plaque Psoriasis FDA Approves Topical Tapinarof for Plaque Psoriasis

Tapinarof is an aryl hydrocarbon receptor agonist and is the first FDA-approved steroid-free topical medication in this class, according to the manufacturer.FDA Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Dermatology News Alert Source Type: news